Journal Pre-proof A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH Youxiang Liang, Song Jiao, Miaomiao Wang, Huimin Yu, Zhongyao Shen PII:
S1096-7176(19)30266-6
DOI:
https://doi.org/10.1016/j.ymben.2019.10.003
Reference:
YMBEN 1611
To appear in:
Metabolic Engineering
Received Date: 27 June 2019 Revised Date:
10 October 2019
Accepted Date: 10 October 2019
Please cite this article as: Liang, Y., Jiao, S., Wang, M., Yu, H., Shen, Z., A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH, Metabolic Engineering (2019), doi: https:// doi.org/10.1016/j.ymben.2019.10.003. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Inc. on behalf of International Metabolic Engineering Society.
1
A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH
2
Youxiang Liang1, 2, Song Jiao1, 2, Miaomiao Wang1, 2, Huimin Yu1,
3 4 5 6 7 8 9
2, 3*
Zhongyao Shen1, 2 1 Department of Chemical Engineering, Tsinghua University, Beijing 100084, China 2 Key Laboratory of Industrial Biocatalysis (Tsinghua University), Ministry of Education, Beijing 100084, China 3 Center for Synthetic and Systems Biology, Tsinghua University, Beijing 100084, China
10
*Corresponding author:
11
Telephone: 86-10-62795492, Fax: 86-10-62770304,
12
E-mail:
[email protected]
13
Address: Yingshi Building 412, Tsinghua University, Beijing, China, 100084
14 15
Manuscript prepared for submission to:
16
Metabolic Engineering
17 18
and
19
Abstract
20
Rhodococcus spp. are organic solvent-tolerant strains with strong adaptive
21
abilities and diverse metabolic activities, and are therefore widely utilized in
22
bioconversion, biosynthesis and bioremediation. However, due to the high
23
GC-content of the genome (~70%), together with low transformation and
24
recombination efficiency, the efficient genome editing of Rhodococcus remains
25
challenging. In this study, we report for the first time the successful establishment of a
26
CRISPR/Cas9-based genome editing system for R. ruber. With a bypass of the
27
restriction-modification system, the transformation efficiency of R. ruber was
28
enhanced by 89-fold, making it feasible to obtain enough colonies for screening of
29
mutants. By introducing a pair of bacteriophage recombinases, Che9c60 and Che9c61,
30
the editing efficiency was improved from 1% to 75%. A CRISPR/Cas9-mediated
31
triple-plasmid recombineering system was developed with high efficiency of gene
32
deletion, insertion and mutation. Finally, this new genome editing method was
33
successfully applied to engineer R. ruber for the bio-production of acrylamide. By
34
deletion of a byproduct-related gene and in-situ subsititution of the natural nitrile
35
hydratase gene with a stable mutant, an engineered strain R. ruber THY was obtained
36
with reduced byproduct formation and enhanced catalytic stability. Compared with
37
the use of wild-type R. ruber TH, utilization of R. ruber THY as biocatalyst increased
38
the acrylamide concentration from 405 g/L to 500 g/L, reduced the byproduct
39
concentration from 2.54 g/L to 0.5 g/L, and enhanced the number of times that cells
40
could be recycled from 1 batch to 4 batches.
41 42
Keywords: Rhodococcus; CRISPR/Cas9; genome editing; restriction-modification
43 44
system; recombinase; acrylamide bio-production
45
1. Introduction
46
Rhodococccus spp. are non-sporulating, aerobic actinomycetes widely distributed
47
in environments with different nutritional conditions (Bell et al., 1998). They possess
48
excellent adaptation abilities and diverse metabolic activities, enabling them to
49
degrade and assimilate a wide range of organic pollutants, including nitriles,
50
halogenated hydrocarbons and numerous aromatic compounds (Bell et al., 1998;
51
DeLorenzo et al., 2018; Warhurst and Fewson, 1994; Xu et al., 2018). The desirable
52
traits make Rhodococcus an ideal candidate for the bioremediation of contaminated
53
environments and a wide range of biotransformations, such as enantioselective
54
synthesis and the production of amides from nitriles (Bell et al., 1998; MethCohn and
55
Wang, 1997; Nagasawa et al., 1993; Wang, 2015; Warhurst and Fewson, 1994). The
56
bio-production of acrylamide from acrylonitrile using Rhodococcus harboring nitrile
57
hydratase has been one of the most successful cases of industrial biotechnology
58
(Nagasawa et al., 1993). Rhodococcus is also an ideal chassis for the production of
59
lipids and biofuels from lignocellulosic biomass, owing to its adaptable tolerance
60
against biomass breakdown products (e.g., furans, halogenated compounds and
61
phenolics) and diverse enzymatic pathways for the assimilation of aromatic
62
compounds (DeLorenzo et al., 2018; Henson et al., 2018). Therefore, the genetic and
63
metabolic engineering of Rhodococcus are of great interest, and efficient genetic tools
64
are urgently required.
65
Although various genetic toolkits such as promoter libraries, reporter genes and
66
shuttle vectors have been developed for Rhodococcus (DeLorenzo et al., 2017;
67
DeLorenzo et al., 2018; Jiao et al., 2018), the genome editing of Rhodococcus remains
68
challenging, due to the high GC content (~70%) in genome, low transformation
69
efficiency and recombination efficiency. For example, the transformation efficiency of
70
most Rhodococcus is usually no more than 105 cfu/µg DNA (Duran, 1998; Sekizaki et
71
al., 1998; Shao et al., 1995), thereby hindering gene knockout that involves rare
72
homologous recombination (Suzuki and Yasui, 2011). In addition, severe illegitimate
73
recombination was found in Rhodococcus, and caused random integration into the
74
genome when a non-replicating vector was introduced (Desomer et al., 1991).
75
Recently, a recombineering method using the recombinases Che9c60 and Che9c61
76
derived from mycobacteriophage (van Kessel and Hatfull, 2007) and a linear
77
double-stranded DNA (dsDNA) template flanking antibiotic resistance genes, was
78
established in R. opacus PD630 with improved editing efficiency (DeLorenzo et al.,
79
2018). However, the antibiotic resistance cassettes could not be recovered from the
80
genome, which limited multiple rounds of genome editing. A two-step
81
double-crossover recombination can recover antibiotic markers but requires an
82
efficient counter-selection marker. Although various counter-selection markers,
83
including upp, sacB and mazF, have been developed for different strains, most of
84
them have limited applicability. For example, upp requires the host strains to be free
85
of the native upp gene (Shi et al., 2013), and mazF requires a strictly inducible
86
promoter for expression (Zhang et al., 2006). SacB has been utilized in many bacteria,
87
including Escherichia coli (Crouzet et al., 1997), Corynebacterium glutamicum
88
(Schafer et al., 1994), Mycobacteria (Pelicic et al., 1996), and some Rhodococcus
89
(van der Geize et al., 2001). However, it did not function in some Rhodococcus such
90
as Rhodococcus equi (van der Geize et al., 2008), and the transformation of the
91
suicide plasmid pK18mobSacB into R. ruber could not effectively confer a
92
sucrose-sensitive phenotype. Thus, an efficient and scarless genome editing method
93
for Rhodococcus still remains to be developed.
94
During the past several years, the clustered regularly interspaced short
95
palindromic repeat (CRISPR) system has emerged as a powerful tool for genome
96
editing in humans, animals, plants and microorganisms (Wang et al., 2016). The type
97
II CRISPR/Cas9 system from Streptococcus pyogenes is the most widely used and
98
well-characterized CRISPR system (Choi and Lee, 2016; Wang et al., 2016). Cas9
99
forms a ribonucleoprotein complex with sgRNA (the fusion of crRNA and tracrRNA)
100
and introduces double-strand breaks (DSBs) on the target DNA with a protospacer
101
adjacent motif (PAM) (Jinek et al., 2012). The DSBs could be repaired by
102
nonhomologous end joining (NHEJ) or homologous recombination, and consequently,
103
the target genes would be inactivated. The CRISPR/Cas9 system has been employed
104
in many microorganisms, including E. coli (Jiang et al., 2015), Saccharomyces
105
cerevisiae (DiCarlo et al., 2013), Bacillus subtilis (Altenbuchner, 2016), Streptomyces
106
(Cobb et al., 2015) and C. glutamicum (Cho et al., 2017), but has not been used in
107
Rhodococcus. Recently, the CRISPR interference (CRISPRi) system was developed
108
in R. opacus PD630 for gene knockdown (DeLorenzo et al., 2018). However, to
109
construct valuable industrial Rhodococcus strains requiring permanent and stable
110
changes, gene knockout rather than gene knockdown is necessary. From CRISPRi to
111
CRISPR, there are still great obstacles to overcome, including not only having Cas9
112
effectively work in the target strain and achieving enough transformation efficiency to
113
obtain mutants, but also achieving high recombination efficiency necessary for the
114
repair of DSBs.
115
In this study, we successfully developed a CRISPR/Cas9-based Rhodococcus
116
genome editing method with a triple-plasmid system for efficient and scarless genome
117
editing, including gene deletion, insertion and mutation. With this powerful tool, we
118
further accomplished the recombineering of R. ruber TH, obtaining a robust and
119
efficient Rhodococcus biocatalyst for the bio-production of acrylamide.
120
2. Materials and Methods
121
2.1. Strains and media
122
The plasmids and strains used in this study are listed in Table S1 and S2,
123
respectively. E. coli Top10 was used for plasmid construction. R. ruber TH was
124
previously isolated from nitrile-containing soil (Ma et al., 2010) and produced NHase
125
for the conversion of acrylonitrile to acrylamide. Luria-Bertani (LB) medium (10 g/L
126
tryptone, 5 g/L yeast extract, 10 g/L NaCl) was used for the cultivation of E. coli, and
127
seed medium (30 g/L glucose, 1 g/L yeast extract, 7 g/L tryptone, 0.5 g/L
128
K2HPO4•3H2O, 0.5 g/L KH2PO4, 0.5 g/L MgSO4•7H2O, 1 g/L monosodium glutamate,
129
pH 7.5) was used for routine cultivation of R. ruber. When required, 25 µg/mL
130
kanamycin, 6 µg/mL tetracycline or 5 µg/mL chloramphenicol was added. For the
131
overexpression of NHase, a seed culture was transferred to fermentation medium (30
132
g/L glucose, 7–8 g/L yeast extract, 10 g/L urea, 2.28 g/L K2HPO4•3H2O, 0.866 g/L
133
KH2PO4, 1 g/L MgSO4•7H2O, 1 g/L monosodium glutamate, 28.55 mg/L CoCl2•6H2O,
134
pH 7.5).
135
2.2. Construction of plasmids
136
A codon-optimized cas9 gene was amplified from the plasmid pCAS9-mCherry
137
(Addgene #80975) (Schmid-Burgk et al., 2016) with primers XbaI-Cas9-F and
138
BamHI-Cas9-R, and the mcherry gene was amplified with XbaI-mcherry-F and
139
KpnI-mcherry-R. The amplified fragments were inserted into plasmid pNV-Pa2 to
140
construct pNV-Pa2-Cas9 and pNV-Pa2-mcherry, respectively. Plasmid pNV-null-Cas9
141
with no promoter for Cas9 was constructed by inserting cas9 gene into plasmid
142
pNV18.1. For the construction of pNV-Pa2-Cas9::mCherry, cas9 was amplified with
143
XbaI-Cas9-F and Cas9-fusion-R, and the mcherry gene was amplified with
144
fusion-mcherry-F and KpnI-mcherry-R. The amplified fragments were fused together
145
by overlap PCR and inserted into pNV-Pa2. Pa2 was a urea-inducible promoter, and
146
its expression relied on native transcriptional regulators in the genome of R. ruber.
147
pNVTc was a derivative of pNV18.1 generated by replacing the KmR gene with
148
the TcR gene. The backbone of pNV18.1 without the KmR gene was amplified with
149
primers pNV-F and pNV-R, and the TcR gene was amplified from the plasmid pPHA
150
(Ma et al., 2010) with the primers fusion-Tc-F and fusion-Tc-R. The fragments were
151
fused together using Gibson Assembly to obtain pNVTc. Similarly, pNVCm1 and
152
pNVCm were derivatives of pNV18.1 with the KmR gene replaced by the CmR gene.
153
The CmR gene with a native promoter was amplified from pXMJ19 with the primers
154
fusion-Cm-F1 and fusion-Cm-R1 and then fused with the backbone of pNV18.1 to
155
construct pNVCm1. To improve the expression level of CmR in R. ruber, the strong
156
constitutive promoter PamiC (Jiao et al., 2018) from Pa2 was amplified from
157
pNV-Pa2 with the primers fusion-PamiC-F and PamiC-R. The CmR gene was
158
amplified from pXMJ19 with the primers fusion-Cm-F and fusion-Cm-R. The
159
amplified fragments were fused by overlap PCR and then ligated with the backbone
160
of pNV18.1 using Gibson Assembly to generate pNVCm.
161
Replicons pB264 (Lessard et al., 2004) and pRC4 (Hashimoto et al., 1992) was
162
synthesized by Qinglan (Wuxi, China). pBNVTc was a derivative of pNVTc obtained
163
by replacing the pAL5000 origin with pB264. Plasmid pNVTc and pB264 were both
164
digested by NheI and ligated together to obtain pBNVTc after the pAL5000 origin
165
was removed. Similarly, pRCTc was constructed by replacing the pAL5000 origin of
166
pNVTc with pRC4, and pBNVCm was constructed by replacing the pAL5000 origin
167
of pNVCm with pB264.
168
The strong constitutive promoter PamiC, free of ribosome-binding sites, was
169
amplified from pNVCm with the primers KpnI-PamiC-F and PamiC-R1, and the
170
sgRNA expression cassette targeting amiE was amplified from pJOE8999
171
(Altenbuchner, 2016) with the primers sgRNA-F1 and XbaI-sgRNA-R. The amplified
172
fragments were fused by overlap PCR and inserted into pBNVTc to construct
173
pBNVTc-sgRNA1. The upstream homologous arm of amiE was amplified from R.
174
ruber TH with the primers XbaI-amiUp-F and amiUp-R, and the downstream arm was
175
amplified with amiDown-F and HindIII-amiDown-R. The fragments were fused and
176
inserted into pBNVTc-sgRNA1 to construct the pBNVTc-sgRNA1-donor.
177
For the quick and easy assembly of the guide sequence with the sgRNA cassette,
178
a BbsI restriction site was introduced. XbaI-PamiC-F and BbsI-PamiC-R were used to
179
amplify PamiC from pNVCm. BbsI-sgRNA-F and KpnI-sgRNA1-R were used to
180
amplify the sgRNA cassette from pJOE8999. The fragments were fused and inserted
181
into pBNVCm to construct pBNVCm-BbsI-sgRNA. Afterward, the pBNVCm-sgRNA
182
series could be generated by Golden Gate Assembly as described by Ran et al. (Ran et
183
al., 2013).
184
The Che9c60&61 gene (DeLorenzo et al., 2018) was synthesized by Qinglan
185
(Wuxi, China). The Che9c60&61 gene was amplified with the primers XbaI-che9c-F
186
and KpnI-che9c-R, and promoter Pa2 was amplified from pNV-Pa2 with the primers
187
HindIII-Pa2-F and XbaI-Pa2-R. The two fragments were inserted into pRCTc to
188
construct pRCTc-Pa2-Che9c60&61. A homologous arm of amiE was amplified from
189
R. ruber with the primers EcoRI-amiE-F and BamHI-amiE-R and inserted into
190
pK18mob, a non-replicating plasmid for Rhodococcus, to construct pK18mob-amiE.
191
The primers used in this study are listed in Table S3. DNA polymerases,
192
restriction enzymes, and T4 DNA ligases were purchased from TaKaRa (Dalian,
193
China) and Vazyme (Nanjing, China). DNA purification kits, gel extraction kits and
194
plasmid extraction kits were purchased from Solarbio (Beijing, China). Gibson
195
Assembly kits were purchased from Taihe Biotechnology (Beijing, China). DNA
196
sequencing was performed by GENEWIZ (Suzhou, China). Plasmids for
197
CRISPR/Cas9
198
pRCTc-Pa2-Che9c60&61 (Addgene #134766) and pBNVCm-BbsI-sgRNA (Addgene
199
#134767) have been deposited to Addgene (website: http://www.addgene.org/).
200
system
including
pNV-Pa2-Cas9
(Addgene
#134765),
2.3. Transformation protocol
201
Plasmids or DNA fragments were introduced into R. ruber by electroporation as
202
described by Jiao et al.(Jiao et al., 2018) with some modifications. R. ruber was
203
cultured in GYKGI media (20 g/L glucose, 5 g/L yeast extract, 0.655 g/L
204
K2HPO4•3H2O, 0.5 g/L KH2PO4, 0.5 g/L MgSO4•7H2O, 8.5 g/L glycine, 1.5 mg/L
205
isoniazid, pH 7.5) at 28°C until OD460 reached 0.3~0.5. The R. ruber cells were
206
collected by centrifugation at 4°C, washed three times with 10% ice-cold glycerol,
207
and finally re-suspended to a 1/200 initial volume with 10% ice-cold glycerol. One
208
microgram of plasmids or DNA fragments were added to 100 µL of competent cells
209
and loaded into an electroporation cuvette with a 2 mm gap. The cuvette was placed
210
in ice for 10 min, and electroporation was performed with a pulse of 12.5 kV/cm. The
211
cells were mixed with 800 µL of LBHIS medium (5 g/L tryptone, 5 g/L NaCl, 2.5 g/L
212
yeast extract, 18.5 g/L brain heart infusion powder and 91 g/L sorbitol) and cultured at
213
28°C for 3 h. The cells were subsequently spread on solid plates (10 g/L glucose, 3
214
g/L yeast extract, 1 g/L NaCl, 2 g/L KH2PO4, 0.2 g/L MgSO4•7H2O, 15 g/L agar) with
215
appropriate antibiotics. Depending on the antibiotics used, the culture time varied
216
from 2 to 5 days.
217
2.4. Growth analysis
218
Recombinant cells of R. ruber TH (Cas9) and TH (pNV18.1) were inoculated
219
from solid plates into seed medium and cultured at 28°C and 200 rpm for 48 h. The
220
seed culture was transferred to new seed medium containing 0 g/L or 6 g/L urea to an
221
initial OD460 of 0.3 and cultured at 28°C and 200 rpm. Samples were taken
222
periodically to monitor the growth conditions.
223
2.5. Fluorescence measurement
224
Cells in the mid-exponential growth phase were centrifuged at 4°C and
225
re-suspended in 10 mM PBS buffer to an OD460 of 1.0. The mCherry expression
226
intensities of recombinant cells were measured using a TECAN Infinite M200 PRO
227
microplate reader (Männedorf, Switzerland) with R. ruber TH (pNV18.1) as the
228
negative control. The excitation and emission wavelengths were 535 and 620 nm,
229
respectively.
230
2.6. Determination of transformation efficiency of plasmids derived from E.
231
coli and R. ruber
232
Plasmid pBNVTc-sgRNA1-donor was constructed using E. coli Top 10, and then
233
transformed
to
R.
ruber
TH
by
electroporation.
To
extract
plasmid
234
pBNVTc-sgRNA1-donor from R. ruber, corresponding R. ruber colonies were
235
inoculated to the seed medium, and cultured at 28℃ and 200 rpm for 36 h when OD460
236
reached 3~5. Two microliter of cell liquid were centrifuged at 13000×g for 2 min.
237
Cells were then re-suspended by 2 mL of 15 mg/mL lysozyme solution (dissolved in
238
Tris-EDTA buffer solution), and then incubated at 37℃ and 200 rpm for 1 h. Cells
239
were harvested by centrifugation at 13000×g for 2 min, and then used for plasmid
240
extraction according to the standard protocol of plasmid extraction kits purchased
241
from Solarbio (Beijing, China). About 30 µL plasmid could be obtained with a
242
concentration about 10 ng/µL.
243
The routine extraction of plasmids from E. coli does not require the extra
244
treatment of lysozyme. However, to exclude the influence of lysozyme, we also
245
included this step in the procedure of plasmid extraction from E. coli. About 80 µL
246
plasmid of 200 ng/µL could be obtained from 2 mL cell liquid. The plasmid solution
247
was diluted to 10 ng/µL, the same as the concentration of plasmid derived from R.
248
ruber.
249
To determine the transformation efficiencies of pBNVTc-sgRNA1-donor derived
250
from R. ruber and E. coli, 100 ng plasmids were added to 100 µL of R.ruber
251
competent cells for electroporation. Colonies were counted for the calculation of
252
transformation efficiency.
253
2.7. Characterization of Che9c60&61 in R. ruber
254
R. ruber was transformed with the plasmid pRCTc-Pa2-Che9c60&61. The
255
subsequent strains were transformed with the suicide plasmid pK18mob-amiE or
256
linear homologous arms of amiE flanking the CmR gene. The growing colonies were
257
tested by colony PCR to determine the editing efficiency. The linear CmR integration
258
cassette was prepared as follows. The upstream and downstream homologous arms of
259
amiE were amplified from R. ruber, the CmR cassette was amplified from pNVCm,
260
and the three fragments were fused together by overlap PCR.
261
2.8. Iterative genome editing protocol
262
Wild-type R. ruber was transformed with the plasmid pNV-Pa2-Cas9 and then
263
made competent for the introduction of pRCTc-Pa2-Che9c60&61. The subsequent R.
264
ruber (Cas9+Che9c60&61) was transformed with 1 µg of the pBNVCm-sgRNA
265
series and 1 µg of linear donor DNA and spread on solid plates containing 25 µg/mL
266
kanamycin, 6 µg/mL tetracycline and 5 µg/mL chloramphenicol. The colonies were
267
verified using appropriate primers, and the edited colonies were used for the next
268
round of editing. Before the introduction of new sgRNA plasmids, the previous
269
pBNVCm-sgRNA must be cured. The edited R. ruber was cultured in seed medium
270
containing 25 µg/mL kanamycin and 6 µg/L tetracycline at 37°C before being spread
271
on solid plates containing the above antibiotics. Subsequently, colonies were picked
272
and streaked on plates containing 5 µg/mL chloramphenicol. Colonies not growing on
273
plates
274
pBNVCm-sgRNA and were selected for the next round of gene editing. Similarly,
275
plasmids pNV-Pa2-Cas9 and pRCTc-Pa2-Che9c60&61 could also be cured from the
276
final edited strains when they were cultured in seed medium and streaked on plates
277
without antibiotics.
278
containing
chloramphenicol
were
bacteria
that
had
already
lost
2.9. NHase and amidase activity assay
279
For the overexpression of NHase, a seed culture of R. ruber was transferred to
280
fermentation medium to an initial OD460 of 3.0 and cultured at 28°C for 54 h. For the
281
measurement of NHase activity, 100 µL of free cells (OD460=50) and 4.5 mL of 50
282
mM PBS were mixed with 200 µL of acrylonitrile and incubated at 28°C for 5 min.
283
The reaction was terminated by adding 200 µL of 3 M HCl. After centrifugation at
284
10000×g for 2 min, the supernatant was analyzed with gas chromatography (Chen et
285
al., 2013). One unit of NHase activity was defined as the amount of cells that
286
produced one µmol of acrylamide per minute.
287
For the measurement of amidase activity, 500 µL of free cells (OD460=50) in 50
288
mM PBS was mixed with 500 µL of 20% acrylamide solution and incubated at 40°C
289
for 1 h. The reaction was terminated by centrifugation at 10,000×g for 2 min, and the
290
supernatant was analyzed with gas chromatography. One unit of amidase activity was
291
defined as the amount of cells that converted one µmol of acrylic acid per minute.
292 293
2.10.
Assessment of catalytic stability of R. ruber
The catalytic stability was assessed by measuring the residual NHase activity of
294
R. ruber after a batch of acrylonitrile hydration. The hydration reaction was
295
performed in a 100 mL flask containing 20 mL of free cells in deionized water
296
(OD460=50). Acrylonitrile (15 mL) was added over 40 min at a velocity of 0.375
297
mL/min. The reaction was kept on ice, as it was strongly exothermic. The cells were
298
recovered by centrifugation at 10000×g for 15 min. The supernatant was analyzed
299
using gas chromatography, and the cells were resuspended to 20 mL with deionized
300
water. Then, 100 µL of cell suspension was taken for the measurement of residual
301
NHase activity.
302
2.11.
Multibatch acrylonitrile hydration
303
Multi-batch acrylonitrile hydration was conducted in a 1000 mL flask containing
304
400 mL of R. ruber cell suspension (1.6 gdcw/L). The initial feeding rate of
305
acrylonitrile was set at 5.8 mL/min and adjusted suitably to maintain the acrylonitrile
306
concentration below 1 g/L. The temperature was maintained between 18 and 25°C.
307
The acrylamide concentration was monitored by taking samples periodically for GC
308
analysis. The reaction was terminated when the acrylamide concentration reached 500
309
g/L or did not continue to increase. Afterward, acrylamide was separated from R.
310
ruber cells using a hollow fiber membrane, and the cells were recovered and used for
311
the next batch of acrylonitrile hydration.
312
3. Results
313 314
3.1. Enabling efficient function of the Cas9-sgRNA complex in R. ruber R.
ruber
TH
is
an
organic
solvent-tolerant
strain
isolated
from
315
nitrile-contaminated soil that has been engineered for the expression of nitrile
316
hydratase (Ma et al., 2010), nitrilase (Sun et al., 2016), and epoxide hydrolase (Liang
317
et al., 2019). The proportion of soluble target enzymes in R. ruber reaches 30%~50%
318
of the total protein (Liang et al., 2019; Sun et al., 2016), indicating its potential as an
319
efficient whole-cell biocatalyst. Despite its desirable traits, further engineering of R.
320
ruber has been hindered by its high GC content (~70%) and low transformation and
321
recombination efficiencies. Compared with that of other microorganisms, such as E.
322
coli, C. glutamicum and B. subtilis, the genome editing of Rhodococcus is quite
323
difficult.
324
To develop the CRISPR/Cas9 system in R. ruber, we first needed to enable the
325
Cas9-sgRNA complex to efficiently introduce DSB in the target genomic locus. As
326
the native Streptococcus pyogenes cas9 gene (GC content 35.1%) contains too many
327
extremely rare codons of R. ruber, a codon-optimized cas9 gene(Schmid-Burgk et al.,
328
2016) (GC content 62%) was selected. The results of the codon usage analysis of the
329
cas9 genes are shown in Fig. S1 and S2. Considering the reported toxicity of Cas9 to
330
the cell growth of some bacteria such as C. glutamicum (Cho et al., 2017) and
331
Halomonas (Qin et al., 2018), we chose a urea-inducible promoter with adjustable
332
intensity for the expression of Cas9, Pa2 (Sun et al., 2016), as shown in Fig. 1a. The
333
efficiency of transforming pNV-Pa2-Cas9 into R. ruber was as low as 45±4 cfu/µg
334
DNA. This was probably caused by the large size (8.83 kb) of the plasmid, as the
335
transformation efficiency of plasmid pNV-null-Cas9 with similar size but no promoter
336
for Cas9 was also as low as 53±6 cfu/µg DNA. Consequently, a two-plasmid system
337
with separated Cas9 and sgRNA was designed to validate the function of the
338
Cas9-sgRNA complex. R. ruber TH was transformed with pNV-Pa2-Cas9 and
339
subsequently made competent for the introduction of a pBNVTc-sgRNA series
340
(sgRNA1, sgRNA2 and sgRNA3, targeting genes amiE, nhh, and nit, respectively), in
341
which the strong constitutive promoter PamiC (Jiao et al., 2018), free of
342
ribosome-binding sites, was used to transcribe the sgRNA cassette (Altenbuchner,
343
2016) (Fig. 1b). As shown in Fig. 1c, the efficiency of transforming pBNVTc-sgRNA
344
into R. ruber TH (Cas9) was three orders of magnitude lower than the transformation
345
efficiency for R. ruber TH. The escape rate of R. ruber for Cas9 cleavage was lower
346
than 10-3, indicating that the Cas9-sgRNA complex could function as an efficient
347
counter-selection marker in R. ruber.
348
349 350
Figure 1. Enabling the function of the Cas9-sgRNA complex in R. ruber. (a)
351
Plasmid map of pNV-Pa2-Cas9. (b) Plasmid map of the pBNVTc-sgRNA series. (c)
352
Transformation efficiencies for the pBNVTc-sgRNA series of plasmids into R. ruber
353
TH or TH (Cas9) with the empty pBNVTc as a control. The plasmids
354
pBNVTc-sgRNA1, pBNVTc-sgRNA2, and pBNVTc-sgRNA3 contained sgRNA
355
targeting amiE, nhh, and nit, respectively. The electroporation was performed as
356
described in section 2.3. Urea was not used in this experiment, and the expression of
357
Cas9 relied on the leaky transcription of promoter Pa2. Experiments were performed
358
in triplicate. (d) Illustration of escape mechanisms determined by sequencing the
359
pNV-Pa2-Cas9 and pBNVTc-sgRNA extracted from the escape colonies.
360 361
We also analyzed the colonies escaping from Cas9 cleavage by DNA sequencing.
362
None of the 8 sequenced colonies showed mutations on the target site of sgRNA in
363
the genome, indicating that NHEJ was not observed in these colonies. Although genes
364
such as Ku and LigD (Shuman and Glickman, 2007) responsible for NHEJ could be
365
found in R. ruber (see Fig. S3), the efficiency of NHEJ seemed to be inadequate for
366
the repair of DSBs caused by Cas9. NHEJ pathways in bacteria such Streptomyces
367
coelicolor (Tong et al., 2015) and M. smegmatis (Sun et al., 2018) could repair DSBs
368
when no templates for homologous recombination were present. However, other
369
species such as Clostridium cellulolyticum were killed by Cas9 cleavage despite the
370
existence of NHEJ pathways (Xu et al., 2015). By sequencing the plasmids extracted
371
from these colonies, we found that either sgRNA or Cas9 was inactivated. As shown
372
in Fig. 1d, 6 colonies showed excision of the sgRNA cassette from plasmid
373
pBNVTc-sgRNA, while the others showed a frame shift mutation on Cas9 or insertion
374
by transposases of R. ruber.
375
Considering the possible toxicity of Cas9, we also analyzed its effect on the cell
376
growth of R. ruber. The fluorescent protein mCherry was fused with Cas9 to measure
377
its expression level. The addition of 6 g/L urea improved the expression of
378
Cas9::mCherry by 5.5-fold but showed no influence on the cell growth of R. ruber
379
(see Fig. S4). Unlike its overexpression in some bacteria such as C. glutamicum (Cho
380
et al., 2017)and Halomonas (Qin et al., 2018), the overexpression of Cas9 seemed to
381
be harmless to R. ruber in the absence of sgRNA.
382
3.2. Limited transformation and recombination efficiencies hinder the
383
CRISPR/Cas9-based genome editing of R. ruber
384
As a proof of concept, amiE, which encodes an aliphatic amidase, was selected
385
for gene knockout with CRISPR/Cas9 as shown in Fig. S5. For the repair of DSBs,
386
homologous arms (approximately 800 bp on each side) of amiE were added to the
387
sgRNA plasmid pBNVTc-sgRNA1 to construct the pBNVTc-sgRNA1 donor.
388
However, nearly no colonies were obtained when the pBNVTc-sgRNA1-donor was
389
introduced to R. ruber TH (Cas9) due to the limited transformation efficiency and
390
recombination efficiency of R. ruber.
391
We could estimate the efficiency of genome editing with CRISPR/Cas9 using the
392
following two equations: colony number = T×(R+E) and editing efficiency = R/(R+E),
393
where T represents the transformation efficiency (cfu/µg DNA) of a sgRNA plasmid,
394
R represents the recombination efficiency and E represents the escape rate.
395
For the plasmid pBNVTc-sgRNA1-donor, the homologous arms added to
396
pBNVTc-sgRNA increased the size from 5.52 kb to 7.17 kb, thereby significantly
397
reducing the transformation efficiency of R. ruber from 1.32×104 to 2.06×103 cfu/µg
398
DNA. Considering the limited recombination pathways of most bacteria, it was
399
difficult to obtain enough colonies for the screening of edited colonies with such
400
transformation efficiencies. Thus, to develop an efficient CRISPR/Cas9 system, we
401
needed to improve both the transformation and recombination efficiencies of R. ruber.
402
3.3. Enhancing
transformation
efficiency
through
bypassing
the
403
Rhodococcus restriction-modification system
404
The transformation efficiency of bacteria is affected by multiple factors,
405
including
competent
cell
preparation,
electroporation
parameters
and
406
restriction-modification (RM) systems (Suzuki and Yasui, 2011). Previous
407
CRISPR/Cas9-associated studies in bacteria such as C. glutamicum (Cho et al., 2017)
408
and Saccharopolyspora erythraea (Liu et al., 2018) focused on the first two factors to
409
improve the transformation efficiency. However, in this study of R. ruber,
410
optimization of the competent cell preparation and electroporation (Jiao et al., 2018)
411
did not effectively improve the transformation efficiency as expected. We thus
412
speculated that the RM system in Rhodococcus might significantly reduce their
413
transformation efficiency. To test this possibility, we compared the transformation
414
efficiency of shuttle vectors extracted from E. coli and R. ruber. As shown in Fig. 2a,
415
the transformation efficiency of plasmid pBNVTc-sgRNA1-donor extracted from R.
416
ruber was 89-fold higher than that extracted from E. coli. We performed Sanger
417
sequencing to the two plasmids but they showed no difference in DNA sequence (see
418
Fig. S6). However, according to Pacbio single-molecule, real-time (SMRT)
419
sequencing data submitted to the Restriction Enzyme Database (REBASE), the
420
methylation patterns in R. ruber and E. coli were quite different as summarized in
421
Table S4. Thus we speculated that the modification status of the plasmids affected
422
their transformation efficiencies to Rhodococccus. That is, the shuttle vectors
423
extracted from E. coli in a routine method might be digested by the restriction
424
enzymes of the target hosts, thereby reducing the transformation efficiency. However,
425
vectors extracted from the target hosts could be methylated by modification systems
426
and avoid digestion when transformed again into the hosts (Fig. 2b). Based on this
427
idea, we proposed a simple but effective strategy to improve the transformation
428
efficiency through bypassing the RM system. In the CRISPR/Cas9 system, the
429
plasmid pBNVTc-sgRNA1-donor could be transformed to R. ruber TH for
430
pre-methylation and then extracted and re-transformed into R. ruber TH(Cas9) to
431
obtain enough colonies for gene knockout.
432
433 434
Figure 2. Enhancing transformation efficiency through bypassing the RM system.
435
(a) The effect of the RM system on the transformation efficiency of the plasmid
436
pBNVTc-sgRNA1-donor. The plasmid was extracted from E. coli and R. ruber and
437
transformed into R. ruber to estimate the efficiency. Experiments were performed in
438
triplicate. (b) Schematic diagram illustrating the bypass of the restriction-modification
439
system.
440
3.4. Enhancing recombination efficiency by introducing heterologous
441
recombinases Che9c60 and Che9c61 and linear donor DNA
442
For the amiE gene knockout, the plasmid pBNVTc-sgRNA1-donor was extracted
443
from R. ruber and transformed into R. ruber TH (Cas9), and 136 colonies were
444
obtained. However, only 1 of 96 colonies picked was amiE-negative, as shown in Fig.
445
3. To improve the editing efficiency, we tried various methods, including the addition
446
of a linear donor and optimization of donor length, but no significant difference was
447
observed. The results indicated that the endogenous recombination pathways of R.
448
ruber were insufficient for the repair of DSBs.
449 450
Figure 3. Gene knockout of amiE with the two-plasmid CRISPR/Cas9 system.
451
The plasmid pBNVTc-sgRNA1-donor was extracted from R. ruber and transformed
452
into R. ruber TH (Cas9) for gene knockout. Primers P1 and P2 were used to examine
453
the edited colonies. A fragment of 1426 bp was amplified from the edited colonies,
454
and a fragment of 2464 bp was amplified from the wild type. Results from 23 of the
455
96 colonies tested are displayed.
456 457
To improve the editing efficiency, exogenous recombination systems are often
458
required to facilitate homologous recombination (Cho et al., 2017; DeLorenzo et al.,
459
2018; Oh and van Pijkeren, 2014; Wang et al., 2018) . In this study, the bacteriophage
460
recombinases Che9c60 and Che9c61 (van Kessel and Hatfull, 2007) were introduced
461
and characterized in R. ruber. Recombinases Che9c60 and Che9c61 are GC-rich
462
homologs of RecE and RecT, respectively. Che9c60 is an exonuclease that produces a
463
single-stranded DNA (ssDNA), and Che9c61 is a ssDNA-binding protein that
464
facilitates strand invasion and exchange of the single-stranded integration cassette into
465
the targeted DNA (van Kessel and Hatfull, 2007). Before incorporating Che9c60&61
466
into the two-plasmid CRISPR/Cas9 system, we first tested whether they could
467
facilitate the homologous recombination of donor DNA supplied on circular plasmids.
468
The plasmid pRCTc-Pa2-Che9c60&61 was constructed with Che9c60&61 driven by
469
the urea-induced promoter Pa2 and then transformed into R. ruber. Subsequently, the
470
non-replicating plasmid pK18mob-amiE containing a homologous sequence of amiE
471
or linear homologous arms of amiE flanking a chloramphenicol resistance (CmR)
472
cassette, was introduced to validate the function of Che9c60&61 in R. ruber. The
473
schematic diagrams of homologous recombination are shown in Fig. S7, and the
474
results are summarized in Table 1.
475
Table 1 Gene knockout of amiE using a suicide plasmid or linear fragment by
476
homologous recombination assisted or not assisted by recombinases Host strains Donors
R. ruber TH
R. ruber TH (Che9c60&61)
Plasmid
Linear
Plasmid
Linear
pK18mob-amiE
amiE-CmR
pK18mob-amiE
amiE-CmR
Colonies
5
0
3
196
Editing efficiency
0/5
-
0/3
8/8
477
Note: Plasmid pK18mob-amiE was a non-replicating plasmid containing a
478
homologous sequence (785 bp) of the gene amiE, and amiE-CmR was a linear
479
integration cassette with the upstream (750 bp) and downstream (750 bp) homologous
480
arms of amiE flanking the CmR gene.
481 482
For the non-replicating plasmid pK18mob-amiE, only 5 and 3 colonies harboring
483
the KmR gene were obtained from R. ruber TH and R. ruber TH (Che9c60&61),
484
respectively, but none of them were amiE-negative regardless of whether
485
Che9c60&61 was used. The results confirmed the severe illegitimate recombination
486
in R. ruber, which caused a low efficiency for gene editing. For linear donor DNA
487
containing the upstream and downstream homologous arms of amiE flanking the CmR
488
gene, no colonies were obtained from R. ruber TH, while 196 colonies were obtained
489
from R. ruber TH (Che9c60&61) with an editing efficiency of 100%. That is,
490
Che9c60&61 can remarkably facilitate the homologous recombination of linear donor
491
DNA in R. ruber over that of plasmid, and the recombination efficiency was
492
successfully enhanced by coupling the introduction of heterologous recombinases
493
Che9c60&61 and linear donor dsDNA.
494
3.5. A triple-plasmid CRISPR/Cas9 recombineering system for genome
495
editing of R. ruber
496
To further incorporate Che9c60&61 into the CRISPR/Cas9 system, we first
497
constructed a plasmid harboring Cas9 and Che9c60&61 but failed to transform it into
498
R. ruber due to its size being too large (11.3 kb). A triple-plasmid system was thus
499
developed as shown in Fig. 4. The plasmid pNV-Pa2-Cas9, expressing Cas9 protein,
500
was first transformed into R. ruber, obtaining the engineered strain R. ruber TH
501
(Cas9).
502
Che9c60&61, was subsequently transformed into TH (Cas9), resulting in the second
503
engineered strain TH (Cas9+Che9c60&61). Then, competent cells of TH
504
(Cas9+Che9c60&61) were prepared and used for co-transformation of the third
505
plasmid containing sgRNA and the linear donor DNA containing the upstream and
506
downstream sequences of the target gene.
507
The
plasmid
pRCTc-Pa2-Che9c60&61,
expressing
recombinases
508
Figure 4. Triple-plasmid CRISPR/Cas9-mediated recombineering system for the
509
genome editing of R. ruber. Plasmids pNV-Pa2-Cas9 and pRCTc-Pa2-Che9c60&61
510
were transformed to R. ruber first, and the subsequent strain was made competent for
511
the introduction of the pBNVCm-sgRNA series and linear donor dsDNA.
512 513
Here, a temperature-sensitive replicon, pB264 (Lessard et al., 2004), was
514
specifically used for the expression of the sgRNA cassette. A CmR gene with its native
515
promoter was first amplified from pXMJ19 to construct the E. coli-Rhodococcus
516
shuttle vector pBNVCm1, but the cultivation time of R. ruber had to be lengthened
517
from 2~3 days to 5~6 days. To solve this problem, the strong constitutive promoter
518
PamiC (Jiao et al., 2018) was utilized to improve the expression level of the CmR
519
gene, and the transformation efficiency of the new plasmid, pBNVCm, into R. ruber
520
reached 4.05×104 cfu/µg DNA in 3 days. For the quick assembly of the guide
521
sequence to sgRNA, a BbsI restriction site was introduced to construct
522
pBNVCm-BbsI-sgRNA (see Fig. S8). In this way, the guide sequences of target genes
523
could be assembled into pBNVCm-BbsI-sgRNA quickly and conveniently via Golden
524
Gate Assembly as described by Ran et al. (Ran et al., 2013).
525
3.6. Gene knockout, insertion and mutation efficiencies of R. ruber with the
526
triple-plasmid CRISPR/Cas9 recombineering system
527
As a proof of concept, the plasmid pBNVCm-sgRNA1 and the linear
528
homologous arms of amiE were co-transformed into R. ruber TH (Cas9+Che9c60&61)
529
for the knockout of amiE. As shown in Fig. 5a, the editing efficiency reached 12/16
530
(75%). This CRISPR/Cas9-based recombineering system was used to successfully
531
knock out several other genes, as summarized in Table 2.
532 533
Table 2 Genome editing with CRISPR/Cas9-based recombineering system Gene editing
Guide sequencea
Deletion
Editing
length (bp)
efficiencyb
534 535 536
amiE deletion
GTGATCCTCATGGCGCTCGC
1038
12/16
nhh deletion
CCCGGGACGGTCTGCGCCCA
1314
2/3
for deletion
AGGAACTCGGCCACAACCGG
1275
4/8
ami deletion
GACCATCCCCGGCGACGAAA
1037
5/24
nit deletion
CGGCATGACCGGATACGGAC
2858
1/32
gfp insertion
GTGATCCTCATGGCGCTCGC
-
1/4
nhh mutation
CCCGGGACGGTCTGCGCCCA
-
20/33
a. The guide sequence was designed using a web-based tool developed by Park et al. (Park et al., 2015) b. Number of edited colonies/total number of transformants.
537 538
Gene insertion and gene mutation were also tested with this system, as shown in
539
Fig. 5b and 5c. The plasmid pBNVCm-sgRNA1 and homologous arms of amiE
540
flanking a gfp gene were co-transformed into R. ruber TH (Cas9+Che9c60&61), and
541
the gene insertion efficiency was 1/4 (25%). Only a minor modification was
542
sometimes needed for the target gene, so the efficiency of introducing in situ point
543
mutations was tested with this system. The homologous arms of nhh flanking a
544
mutated nhh gene were co-transformed with pBNVCm-sgRNA2 into R. ruber TH
545
(Cas9+Che9c60&61). The NGG for the guide sequence on the wild-type nhh gene
546
was changed to NCG on the mutated sequence, so the edited sequence would avoid
547
cleavage by Cas9. The editing efficiency for a single point mutation reached 20/33
548
(60%). The results demonstrated that the CRISPR/Cas9-based recombineering system
549
was efficient for gene knockout, insertion and mutation.
550
551 552
Figure 5. Gene knockout, insertion and mutation using the CRISPR/Cas9 system.
553
(a) Deletion of the amiE gene encoding amidase. Primers P1 and P2 were used to
554
examine the edited colonies. A fragment of 1426 bp was amplified from the edited
555
colonies, and a fragment of 2464 bp was amplified from the wild type. (b) Insertion of
556
a gfp gene. The expression of GFP was visually identified by a Nikon Eclipse Ti-E
557
inverted fluorescence microscope. (d) Mutation of the nhh gene encoding nitrile
558
hydratase (NHase). The mutation was confirmed by Sanger sequencing.
559
3.7. Iterative gene-editing protocol with the CRISPR/Cas9 system
560
As the CRISPR/Cas9-based recombineering was successful for the knockout of a
561
single gene, we further aimed to develop it for multiple gene editing, which requires
562
an iterative protocol. For this process, the sgRNA plasmid in the edited cells must be
563
cured before the introduction of the next sgRNA plasmid. As stated above, the
564
replicon pB264 for the pBNVCm-sgRNA series was temperature-sensitive and could
565
be cured when the cells were cultured at 37°C. As shown in Fig. 6, the edited cells
566
harboring three plasmids could be cultured at 37°C without chloramphenicol for the
567
curing of pBNVCm-sgRNA, and the loss rate of the plasmid reached 100% (see Fig.
568
S9). The subsequent cells could be made competent for the next round of gene
569
editing.
570
To obtain the final edited strains, all three plasmids were simultaneously cured
571
with culturing at 37°C without any antibiotics. For plasmids pNV-Pa2-Cas9 and
572
pRCTc-Pa2-Che9c60&61, although no temperature-sensitive version of the replicons
573
was available, the two plasmids were unstable in the absence of antibiotics probably
574
due to the burden caused by Cas9 and Che9c60&61. The simultaneous curing
575
efficiency of the three plasmids reached 25% (see Fig. S9), which was acceptable for
576
the screening of plasmid-free edited strains.
577
578 579
Figure 6. Scheme of iterative genome editing in R. ruber. When a round of
580
genome editing finished, the plasmid pBNVCm-sgRNA in the edited cells could be
581
cured at 37°C with Tc and Km but without Cm, and the subsequent strain would be
582
used for the next round of editing. Three plasmids in the final edited strains could also
583
be cured simultaneously by culturing at 37°C without any antibiotics.
584
3.8. Engineering a R. ruber whole-cell biocatalyst for acrylamide production
585
using the novel CRISPR/Cas9 tool
586
As a proof-of-concept example, we applied the CRISPR/Cas9 system in the
587
engineering of R. ruber as a whole cell biocatalyst for the bio-production of
588
acrylamide from acrylonitrile. The metabolic pathways of acrylonitrile in R. ruber are
589
shown in Fig. 7a. R. ruber harboring nitrile hydratase (NHase) has been successfully
590
applied in the bio-production of acrylamide from acrylonitrile. However, the substrate
591
acrylonitrile could be converted by nitrilase into acrylic acid and the product
592
acrylamide could also be further catalyzed by amidase into acrylic acid, resulting in
593
reduced acrylamide yield and increased separation cost. NHase has been cloned in
594
some host strains free of nitrile metabolism, such as E. coli (Chen et al., 2013) and C.
595
glutamicum (Kang et al., 2014), but their application was limited by low enzyme
596
stability or activity. Therefore, native NHase-producing Rhodococcus strains are still
597
preferred for industrial-scale production of acrylamide.
598
To address the problem of byproduct formation, related genes in R. ruber TH
599
were analyzed. One gene of R. ruber TH was predicted to be nitrilase, and 24 genes
600
were predicted to be amidases (See Table S5). As nitrilase and NHase compete for the
601
same substrate (acrylonitrile), it was difficult to measure the nitrilase activity of
602
wild-type Rhodococcus. Thus, a NHase-negative Rhodococcus was constructed, and it
603
showed no nitrilase activity toward acrylonitrile as shown in Fig. S10, indicating that
604
in R. ruber
605
formation. Among the 24 predicted amidases, one aliphatic amidase gene (amiE)
606
reported by Ma et al. (Ma et al., 2010) was selected and knocked out, reducing the
607
amidase activity of R. ruber by 60%, as shown in Fig. 7b and 7c.
amidases rather than a nitrilase were responsible for byproduct
608
The enhancement of the enzyme stability of NHase is also urgently needed owing
609
to the inactivation caused by harsh conditions, including the strong exothermic
610
reaction of acrylonitrile to acrylamide and the high toxicity of polar organic solvents.
611
Previously, a mutant NHase was obtained in our laboratory and showed enhanced
612
stability during acrylonitrile hydration (Yu et al., 2017), but plasmid-based expression
613
of the mutant NHase in R. ruber was affected by the natively overexpressed wild-type
614
NHase and plasmid stability. Thus, based on the amiE-negative R. ruber strain TH△
615
amiE, we performed an iterative procedure to replace the wild-type NHase with the
616
mutant and obtained R. ruber THY. The NHase activity of the engineered strain THY
617
(4976±209 U/mL) showed no significant difference from that of TH and TH△amiE
618
(see Fig. S11), but its catalytic stability was enhanced significantly. The activity
619
retained by THY after one batch of acrylonitrile hydration was 62%, while that
620
retained by R. ruber TH△amiE was only 28%, as shown in Fig. 7d.
621
R. ruber THY was then utilized for multi-batch bio-production of high
622
concentrations of acrylamide from acrylonitrile. After 2.7 h of acrylonitrile hydration
623
using free cells of THY (1.6 gdcw/L) as biocatalyst, the concentration of acrylamide
624
reached 500 g/L with a byproduct acrylic acid concentration as low as 0.5 g/L, and the
625
cells could be recycled 4 times, as shown in Fig. 7e and 7f. Compared with the results
626
using wild-type R. ruber TH, the formation of the byproduct acrylic acid was reduced
627
by 80%, the final concentration of acrylamide was improved by 23.5%, and the
628
number of times that the cells could be recycled was enhanced by 3-fold.
629
630 631
Figure 7. Applying CRISPR/Cas9-based recombineering to engineer R. ruber for
632
the bio-production of acrylamide. (a) Acrylonitrile-degradation pathways in R. ruber.
633
(b) Iterative genome editing to delete one amidase gene and replace the wild-type
634
NHase with a mutant NHase. (c) Amidase activity of the engineered R. ruber. (d)
635
Residual NHase activity of engineered R. ruber after a batch of acrylonitrile hydration.
636
(e) Multi-batch acrylonitrile hydration using R. ruber as biocatalyst. (f) Acrylic acid
637
concentration during the first batch of acrylonitrile hydration.
638
4. Discussion
639
The CRISPR/Cas9 system has emerged as a powerful genome editing tool in
640
animals, plants, and microorganisms. Nevertheless, this system has not been applied
641
in some non-model strains with desirable traits but lacking of genetic tractability.
642
Rhodococcus spp. are known as organic solvent-tolerant strains with diverse
643
metabolic pathways and play an important role in bioremediation, biotransformation,
644
and bioconversion (Bell et al., 1998). For example, R. ruber TH has been engineered
645
as a robust and efficient whole-cell biocatalyst for the overexpression of NHase,
646
nitrilase and epoxide hydrolase (Liang et al., 2019; Ma et al., 2010; Sun et al., 2016).
647
Their desirable traits make Rhodococcus a promising platform for biotransformation,
648
which often involves harsh conditions such as toxic organic solvents. However,
649
genome editing of Rhodococcus is still difficult due to the low transformation and
650
recombination efficiencies. In this study, we adopted strategies to overcome the two
651
bottlenecks and developed an efficient CRISPR/Cas9-mediated method in R. ruber
652
for gene knockout, insertion and mutation.
653
The transformation efficiency determines whether enough colonies could be
654
obtained for the screening of mutants. Transformation is affected by multiple factors,
655
including the physical barrier of cell surface structures, electric stress during
656
electroporation, and the RM system of the target host (Suzuki and Yasui, 2011).
657
Previous studies to develop a CRISPR system in bacteria mainly focused on the
658
optimization of competent cell preparation and electroporation to enhance the
659
transformation efficiency (Cho et al., 2017; Liu et al., 2018). However, for R. ruber,
660
the RM system was the critical barrier hindering the transformation of plasmids.
661
Bypassing the RM system improved the transformation efficiency of R. ruber by
662
89-fold and made the screening of edited colonies feasible. Nevertheless, the method
663
required the extraction of the plasmid pBNVTc-sgRNA1-donor from R. ruber TH,
664
which was time-consuming and laborious. Some more convenient methods to bypass
665
RM systems have been reported, including the knockout of key restriction enzymes of
666
the target host (Holt et al., 2012), in vitro methylation of plasmids (Zhao et al., 2018),
667
and the construction of engineered E. coli hosts for plasmid artificial modification
668
(Suzuki and Yasui, 2011). For further research, restriction enzymes should be
669
analyzed and knocked out to construct a mutant strain with high transformation
670
efficiency, or an effective modification method should be established for R. ruber.
671
The recombination efficiency determines the ratio of edited colonies to the
672
overall number of colonies obtained and is also called the editing efficiency. Due to
673
the limitations of endogenous recombination pathways in most bacteria, exogenous
674
recombination systems such as λ-Red and RecET are often required to facilitate
675
genome editing in E. coli (Jiang et al., 2015), C. gultamicum (Wang et al., 2018), and
676
Lactobacillus reuteri (Oh and van Pijkeren, 2014). Previously, a pair of bacteriophage
677
recombinases, Che9c60&61, were introduced into R. opacus PD630 and
678
constitutively expressed for gene knockout with a linear antibiotic integration
679
cassette(DeLorenzo et al., 2018). In this work, we successfully introduced
680
Che9c60&61 into R. ruber and overcame the low recombination efficiency of R.
681
ruber, improving the editing efficiency of the CRISPR/Cas9 system from 1% to 75%.
682
The establishment of the CRISPR/Cas9 system has expanded our ability to
683
engineer Rhodococcus to meet the requirements of industrial applications. Previously,
684
only
685
recombineering using a linear integration cassette were available for the genome
686
editing of Rhodococcus. However, the former is affected greatly by illegitimate
687
recombination in Rhodococcus (Desomer et al., 1991), while the latter is limited by
688
the recovery of antibiotic cassettes when multiple rounds of editing are needed. With
689
the CRISPR/Cas9 system developed in this study, we achieved efficient and scarless
690
gene knockout and mutation. As an example, R. ruber was engineered as a robust
691
whole-cell biocatalyst for the production of acrylamide, an important bulk chemical
692
whose polymer is widely used for enhanced oil recovery and water treatment (Ma et
693
al., 2010). The industrial bio-production of acrylamide has suffered from the
694
byproduct formation caused by the competing pathways such as amidase and nitrilase,
695
as well as the insufficient enzyme stability of NHase. Iteratively knocking out the
696
critical byproduct-related amidase gene and replacing the wild-type NHase in the
697
genome with a stable mutant with the CRISPR/Cas9 system reduced the byproduct
698
formation by 80%, improved the acrylamide concentration by 23.5%, and enhanced
traditional
homologous
recombination
using
suicide
plasmids
and
699
the number of times that the cells could be recycled by 3-fold. With the knockout of
700
the competing pathway and the enhancement of the target pathway, the engineered
701
strain showed great potential for industrial-scale production of acrylamide with
702
reduced energy and material consumption.
703
In summary, a CRISPR/Cas9-based recombineering system was developed in R.
704
ruber for efficient and scarless genome editing, including gene deletion, insertion and
705
mutation. The genome editing tool was successfully utilized to engineer the organic
706
solvent-tolerant strain R. ruber as a robust and efficient whole-cell biocatalyst with
707
reduced byproduct formation and enhanced catalytic stability for the bio-production
708
of acrylamide. It is expected that through some modifications, the system will be
709
extended to other Rhodococcus strains.
710 711
Acknowledgments: We thank Professor Jun Ishikawa (Japan) for supplying plasmid
712
pNV18.1.
713
Funding: This work was supported by the National Natural Science Foundation of
714
China (No. 21776157; No. 21476126).
715
Conflict of Interest: The authors declare that they have no conflict of interest.
716
References
717
Altenbuchner, J., 2016. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9
718 719 720
System. Appl Environ Microb. 82, 5421-5427. Bell, K. S., Philp, J. C., Aw, D. W. J., Christofi, N., 1998. A review - The genus Rhodococcus. J Appl Microbiol. 85, 195-210.
721
Chen, J., Yu, H. M., Liu, C. C., Liu, J., Shen, Z. Y., 2013. Improving stability of nitrile
722
hydratase by bridging the salt-bridges in specific thermal-sensitive regions. J
723
Biotechnol. 164, 354-362.
724
Cho, J. S., Choi, K. R., Prabowo, C. P. S., Shin, J. H., Yang, D., Jang, J., Lee, S. Y.,
725
2017. CRISPR/Cas9-coupled recombineering for metabolic engineering of
726 727 728
Corynebacterium glutamicum. Metab Eng. 42, 157-167. Choi, K. R., Lee, S. Y., 2016. CRISPR technologies for bacterial systems: Current achievements and future directions. Biotechnol Adv. 34, 1180-1209.
729
Cobb, R. E., Wang, Y., Zhao, H., 2015. High-efficiency multiplex genome editing of
730
Streptomyces species using an engineered CRISPR/Cas system. ACS Synth
731
Biol. 4, 723-8.
732
Crouzet, J., Naudin, L., Orsini, C., Vigne, E., Ferrero, L., LeRoux, A., Benoit, P.,
733
LAtta, M., Torrent, C., Branellec, D., Denefle, P., Mayaux, J. F., Perricaudet,
734
M., Yeh, P., 1997. Recombinational construction in Escherichia coli of
735
infectious adenoviral genomes. P Natl Acad Sci USA. 94, 1414-1419.
736
DeLorenzo, D. M., Henson, W. R., Moon, T. S., 2017. Development of Chemical and
737
Metabolite Sensors for Rhodococcus opacus PD630. ACS Synth Biol. 6,
738
1973-1978.
739
DeLorenzo, D. M., Rottinghaus, A. G., Henson, W. R., Moon, T. S., 2018. Molecular
740
Toolkit for Gene Expression Control and Genome Modification in
741
Rhodococcus opacus PD630. ACS Synth Biol. 7, 727-738.
742
Desomer, J., Crespi, M., Vanmontagu, M., 1991. Illegitimate Integration of
743
Non-Replicative Vectors in the Genome of Rhodococcus-Fascians Upon
744
Electrotransformation as an Insertional Mutagenesis System. Mol Microbiol. 5,
745
2115-2124.
746
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., Church, G. M., 2013.
747
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems.
748
Nucleic Acids Res 41, 4336-4343.
749
Duran, R., 1998. New shuttle vectors for Rhodococcus sp. R312 (formerly
750
Brevibacterium sp. R312), a nitrile hydratase producing strain. J Basic Microb.
751
38, 101-106.
752
Hashimoto, Y., Nishiyama, M., Yu, F., Watanabe, I., Horinouchi, S., Beppu, T., 1992.
753
Development of a Host Vector System in a Rhodococcus Strain and Its Use for
754
Expression of the Cloned Nitrile Hydratase Gene-Cluster. J Gen Microbiol.
755
138, 1003-1010.
756
Henson, W. R., Campbell, T., DeLorenzo, D. M., Gao, Y., Berla, B., Kim, S. J., Foston,
757
M., Moon, T. S., Dantas, G., 2018. Multi-omic elucidation of aromatic
758
catabolism in adaptively evolved Rhodococcus opacus. Metab Eng. 49, 69-83.
759
Holt, J. P., Grant, A. J., Coward, C., Maskell, D. J., Quinlan, J. J., 2012. Identification
760
of Cj1051c as a major determinant for the restriction barrier of Campylobacter
761
jejuni strain NCTC11168. Appl Environ Microbiol. 78, 7841-8.
762
Jiang, Y., Chen, B., Duan, C. L., Sun, B. B., Yang, J. J., Yang, S., 2015. Multigene
763
Editing in the Escherichia coli Genome via the CRISPR-Cas9 System. Appl
764
Environ Microb. 81, 2506-2514.
765
Jiao, S., Yu, H. M., Shen, Z. Y., 2018. Core element characterization of Rhodococcus
766
promoters and development of a promoter-RBS mini-pool with different
767
activity levels for efficient gene expression. New Biotechnol. 44, 41-49.
768
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., Charpentier, E., 2012.
769
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive
770
Bacterial Immunity. Science. 337, 816-821.
771
Kang, M. S., Han, S. S., Kim, M. Y., Kim, B. Y., Huh, J. P., Kim, H. S., Lee, J. H.,
772
2014. High-level expression in Corynebacterium glutamicum of nitrile
773
hydratase from Rhodococcus rhodochrous for acrylamide production. Appl
774
Microbiol Biot. 98, 4379-4387.
775
Lessard, P. A., O'Brien, X. M., Currie, D. H., Sinskey, A. J., 2004. pB264, a small,
776
mobilizable, temperature sensitive plasmid from Rhodococcus. BMC
777
Microbiol. 4.
778
Liang, Y., Jiao, S., Wang, M., Yu, H., Shen, Z., 2019. Overexpression of epoxide
779
hydrolase in Rhodococcus ruber with high robustness for the synthesis of
780
chiral epichlorohydrin. Process Biochem. 79, 49-56.
781
Liu, Y., Wei, W. P., Ye, B. C., 2018. High GC Content Cas9-Mediated
782
Genome-Editing
and
Biosynthetic
Gene
Cluster
783
Saccharopolyspora erythraea. ACS Synth Biol. 7, 1338-1348.
Activation
in
784
Ma, Y. C., Yu, H. M., Pan, W. Y., Liu, C. C., Zhang, S. L., Shen, Z. Y., 2010.
785
Identification of nitrile hydratase-producing Rhodococcus ruber TH and
786
characterization of an amiE-negative mutant. Bioresource Technol. 101,
787
285-291.
788
MethCohn, O., Wang, M. X., 1997. An in-depth study of the biotransformation of
789
nitriles into amides and/or acids using Rhodococcus rhodochrous AJ270. J
790
Chem Soc Perk T 1. 1099-1104.
791
Nagasawa, T., Shimizu, H., Yamada, H., 1993. The Superiority of the 3rd-Generation
792
Catalyst,
793
Industrial-Production of Acrylamide. Appl Microbiol Biot. 40, 189-195.
794
Oh, J. H., van Pijkeren, J. P., 2014. CRISPR-Cas9-assisted recombineering in
795 796 797
Rhodococcus-Rhodochrous
J1
Nitrile
Hydratase,
for
Lactobacillus reuteri. Nucleic Acids Res. 42, e131. Park, J., Bae, S., Kim, J. S., 2015. Cas-Designer: a web-based tool for choice of CRISPR-Cas9 target sites. Bioinformatics. 31, 4014-4016.
798
Pelicic, V., Reyrat, J. M., Gicquel, B., 1996. Expression of the Bacillus subtilis sacB
799
gene confers sucrose sensitivity on mycobacteria. J Bacteriol. 178, 1197-1199.
800
Qin, Q., Ling, C., Zhao, Y., Yang, T., Yin, J., Guo, Y., Chen, G. Q., 2018.
801
CRISPR/Cas9 editing genome of extremophile Halomonas spp. Metab Eng.
802
47, 219-229.
803 804
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., Zhang, F., 2013. Genome engineering using the CRISPR-Cas9 system. Nature Protoc. 8, 2281-2308.
805
Schafer, A., Tauch, A., Jager, W., Kalinowski, J., Thierbach, G., Puhler, A., 1994.
806
Small Mobilizable Multipurpose Cloning Vectors Derived from the
807
Escherichia-Coli Plasmids Pk18 and Pk19 - Selection of Defined Deletions in
808
the Chromosome of Corynebacterium-Glutamicum. Gene. 145, 69-73.
809
Schmid-Burgk, J. L., Honing, K., Ebert, T. S., Hornung, V., 2016. CRISPaint allows
810
modular base-specific gene tagging using a ligase-4-dependent mechanism.
811
Nature Commun. 7.
812
Sekizaki, T., Tanoue, T., Osaki, M., Shimoji, Y., Tsubaki, S., Takai, S., 1998.
813
Improved electroporation of Rhodococcus equi. J Vet Med Sci. 60, 277-279.
814
Shao, Z., Dick, W. A., Behki, R. M., 1995. An Improved Escherichia-Coli
815
Rhodococcus Shuttle Vector and Plasmid Transformation in Rhodococcus Spp
816
Using Electroporation. Lett Appl Microbiol. 21, 261-266.
817
Shi, T., Wang, G. L., Wang, Z. W., Fu, J., Chen, T., Zhao, X. M., 2013. Establishment
818
of a Markerless Mutation Delivery System in Bacillus subtilis Stimulated by a
819
Double-Strand Break in the Chromosome. Plos One. 8.
820 821
Shuman, S., Glickman, M. S., 2007. Bacterial DNA repair by non-homologous end joining. Nat Rev Microbiol. 5, 852-61.
822
Sun, B., Yang, J., Yang, S., Ye, R. D., Chen, D., Jiang, Y., 2018. A
823
CRISPR-Cpf1-Assisted Non-Homologous End Joining Genome Editing
824
System of Mycobacterium smegmatis. Biotechnol J. 13, e1700588.
825
Sun, J. Z., Yu, H. M., Chen, J., Luo, H., Shen, Z. Y., 2016. Ammonium acrylate
826
biomanufacturing by an engineered Rhodococcus ruber with nitrilase
827
overexpression and double-knockout of nitrile hydratase and amidase. J Ind
828
Microbiol Biot. 43, 1631-1639.
829
Suzuki, T., Yasui, K., 2011. Plasmid Artificial Modification: A Novel Method for
830
Efficient DNA Transfer into Bacteria. Methods Mol Biol. 765, 309-326.
831
Tong, Y., Charusanti, P., Zhang, L., Weber, T., Lee, S. Y., 2015. CRISPR-Cas9 Based
832
Engineering of Actinomycetal Genomes. ACS Synth Biol. 4, 1020-9.
833
van der Geize, R., de Jong, W., Hessels, G. I., Grommen, A. W., Jacobs, A. A.,
834
Dijkhuizen, L., 2008. A novel method to generate unmarked gene deletions in
835
the
836
conditional lethality. Nucleic Acids Res. 36, e151.
intracellular
pathogen
Rhodococcus
equi
using
5-fluorocytosine
837
van der Geize, R., Hessels, G. I., van Gerwen, R., van der Meijden, P., Dijkhuizen, L.,
838
2001. Unmarked gene deletion mutagenesis of kstD, encoding 3-ketosteroid
839
Delta(1)-dehydrogenase, in Rhodococcus erythropolis SQ1 using sacB as
840
counter-selectable marker. Fems Microbiol Lett. 205, 197-202.
841
van Kessel, J. C., Hatfull, G. F., 2007. Recombineering in Mycobacterium
842
tuberculosis. Nat Methods. 4, 147-52.
843
Wang, B., Hu, Q. T., Zhang, Y., Shi, R. L., Chai, X., Liu, Z., Shang, X. L., Zhang, Y.,
844
Wen, T. Y., 2018. A RecET-assisted CRISPR-Cas9 genome editing in
845
Corynebacterium glutamicum. Microb Cell Fact. 17.
846 847 848 849 850 851
Wang, H. F., La Russa, M., Qi, L. S., 2016. CRISPR/Cas9 in Genome Editing and Beyond. Annu Rev Biochem. 85, 227-264. Wang, M. X., 2015. Enantioselective Biotransformations of Nitriles in Organic Synthesis. Accounts Chem Res. 48, 602-611. Warhurst, A. M., Fewson, C. A., 1994. Biotransformations Catalyzed by the Genus Rhodococcus. Crit Rev Biotechnol. 14, 29-73.
852
Xu, R., Zhang, K., Liu, P., Han, H. W., Zhao, S., Kakade, A., Khan, A., Du, D. L., Li,
853
X. K., 2018. Lignin depolymerization and utilization by bacteria. Bioresource
854
Technol. 269, 557-566.
855
Xu, T., Li, Y., Shi, Z., Hemme, C. L., Li, Y., Zhu, Y., Van Nostrand, J. D., He, Z.,
856
Zhou, J., 2015. Efficient Genome Editing in Clostridium cellulolyticum via
857
CRISPR-Cas9 Nickase. Appl Environ Microbiol. 81, 4423-31.
858 859
Yu, H., Jiao, S., Zhang, j., Shen, Z., An engineered nitrile hydratase and its application. Vol. CN107177581A, China, 2017.
860
Zhang, X. Z., Yan, X., Cui, Z. L., Hong, Q., Li, S. P., 2006. mazF, a novel
861
counter-selectable marker for unmarked chromosomal manipulation in
862
Bacillus subtilis. Nucleic Acids Res. 34.
863
Zhao, H., Xu, L., Rong, Q., Xu, Z., Ding, Y., Zhang, Y., Wu, Y., Li, B., Ji, X., 2018.
864
Application of methylation in improving plasmid transformation into
865
Helicobacter pylori. J Microbiol Methods. 150, 18-23.
866
Highlights Bypassing RM system of Rhodococcus enhanced the transformation efficiency by 89-fold. Introducing bacteriophage recombinases enabled dsDNA recombineering of Rhodococcus. A CRISPR/Cas9 method was developed for Rhodococcus genome editing for the first time. The engineered Rhodococcus could achieve 50% acrylamide production for 4 batches.